Back
Also listed as
LTGHY
OTC
Day Range
$0.68
$0.72
52-Week Range
$0.68
$0.82
Volume
87
50D / 200D Avg
$0.73
/
$0.78
Prev Close
$0.68
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 4.4 | 0.3 |
| P/B | 1.5 | 3.0 |
| ROE % | 3.4 | 3.7 |
| Net Margin % | 15.4 | 3.8 |
| Rev Growth 5Y % | -51.9 | 10.0 |
| D/E | 6.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.63
$1.61 – $1.68
|
29.47B | 1 |
| FY2027 |
$1.51
$1.49 – $1.56
|
27.87B | 1 |
| FY2026 |
$1.33
$1.32 – $1.37
|
26.43B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-05-20 | N/A | -$0.08 | — |
| 2024-11-26 | N/A | $0.16 | — |
| 2024-05-22 | N/A | $0.13 | — |
| 2024-02-22 | N/A | -$0.01 | — |
| 2023-03-31 | N/A | $0.02 | — |
| 2022-09-30 | N/A | $0.04 | — |
| 2022-03-31 | N/A | $0.03 | — |
| 2021-09-30 | $0.03 | $0.04 | +24.9% |
Dividend History
Yield
0.02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 19, 2025 | Dec 22, 2025 | $0.02 | 21.18% |
| Sep 19, 2025 | Sep 22, 2025 | $0.13 | 25.75% |
| Jun 13, 2025 | Jun 17, 2025 | $0.01 | 8.37% |
| Jan 10, 2025 | Jan 13, 2025 | $0.04 | 38.34% |
| Dec 13, 2024 | Dec 17, 2024 | $0.02 | 34.46% |
| Jun 14, 2024 | Jun 18, 2024 | $0.01 | 64.63% |
| Apr 03, 2024 | Apr 08, 2024 | $0.32 | 45.75% |
| Dec 12, 2023 | Dec 18, 2023 | $0.01 | 2.49% |
| Jun 13, 2023 | Jun 19, 2023 | $0.01 | 2.33% |
| Dec 07, 2022 | Dec 12, 2022 | $0.01 | 2.22% |
| Jun 14, 2022 | Jun 20, 2022 | $0.01 | 1.88% |
| Dec 08, 2021 | Dec 13, 2021 | $0.02 | 0.95% |
| Dec 11, 2019 | Dec 17, 2019 | $0.04 | 2.71% |
| Jun 19, 2019 | Jun 24, 2019 | $0.03 | 3.00% |
| Dec 12, 2018 | Dec 18, 2018 | $0.04 | 3.27% |
| Jun 20, 2018 | Jun 25, 2018 | $0.03 | 2.86% |
| Jan 03, 2018 | Jan 08, 2018 | $0.04 | 3.68% |
| Jun 28, 2017 | Jul 03, 2017 | $0.03 | 3.08% |
| Dec 13, 2016 | Dec 19, 2016 | $0.07 | 3.54% |
| Jun 10, 2016 | — | $0.04 | 3.93% |
Key Takeaways
Revenue declined -51.86% annually over 5 years
Earnings declined -95.40% over the past year
ROE of 3.37% is below average
Net margin of 15.39% shows strong profitability
Debt/Equity of 6.04 — high leverage
Generating 138.29M in free cash flow
Growth
Revenue Growth (5Y)
-51.86%
Revenue (1Y)-94.34%
Earnings (1Y)-95.40%
FCF Growth (3Y)-3.77%
Quality
Return on Equity
3.37%
ROIC2.06%
Net Margin15.39%
Op. Margin8.77%
Safety
Debt / Equity
6.04
Current Ratio0.07
Interest Coverage6.38
Valuation
P/E Ratio
4.40
Forward P/EN/A
P/B Ratio1.50
EV/EBITDA37.22
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -94.34% | Revenue Growth (3Y) | -74.89% |
| Earnings Growth (1Y) | -95.40% | Earnings Growth (3Y) | -8.26% |
| Revenue Growth (5Y) | -51.86% | Earnings Growth (5Y) | -40.34% |
| Profitability | |||
| Revenue (TTM) | 1.44B | Net Income (TTM) | 222.18M |
| ROE | 3.37% | ROA | 15.04% |
| Gross Margin | 23.29% | Operating Margin | 8.77% |
| Net Margin | 15.39% | Free Cash Flow (TTM) | 138.29M |
| ROIC | 2.06% | FCF Growth (3Y) | -3.77% |
| Safety | |||
| Debt / Equity | 6.04 | Current Ratio | 0.07 |
| Interest Coverage | 6.38 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 4.40 | Forward P/E | N/A |
| P/B Ratio | 1.50 | P/S Ratio | 0.68 |
| PEG Ratio | -0.92 | Forward PEG | N/A |
| EV/EBITDA | 37.22 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 14.13% | ||
| Market Cap | 978.68M | Enterprise Value | 4.71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.44B | 25.52B | 22.89B | 28.21B | 26.89B |
| Net Income | 222.18M | 4.83B | 264.00M | 1.53B | 1.75B |
| EPS (Diluted) | 0.15 | 3.26 | 0.18 | 1.05 | 1.14 |
| Gross Profit | 336.20M | 17.81B | 6.48B | 5.87B | 18.35B |
| Operating Income | 126.56M | 2.90B | 2.44B | 2.76B | 3.01B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.48B | 24.34B | 45.62B | 42.24B | 40.78B |
| Total Liabilities | 779.01M | 10.83B | 24.33B | 22.38B | 21.61B |
| Shareholders' Equity | 654.18M | 12.54B | 20.21B | 18.75B | 18.07B |
| Total Debt | 3.95B | 4.42B | 13.19B | 13.69B | 12.55B |
| Cash & Equivalents | 219.08M | 2.46B | 846.00M | 2.80B | 2.67B |
| Current Assets | 486.74M | 7.54B | 29.41B | 7.78B | 7.41B |
| Current Liabilities | 7.05B | 5.27B | 11.20B | 7.65B | 7.39B |